Cardiovascular Insufficiency: Clinical Trials

5 trials for Cardiovascular Insufficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 terminated. 2 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Terminated 1
Phase 31Completed 1

Follow Cardiovascular Insufficiency: new trials by email Literature Review of Cardiovascular Insufficiency trials Research Report on Cardiovascular Insufficiency

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fluid Challenge Impact in the Portal Vein Pulsatility Depending on the Fluid Responsivness Status
Cardiovascular Insufficiency, Venous Congestion
CompletedHospices Civils de Lyon362023-07-102024-06-07
Validation of a Walk-Time Limit Test (WTLT) Derived from the 6-Minute Walk Test (6-MWT) in Patients with Chronic Cardiovascular or Respiratory Diseases
6-minute walk test, Walk-Time Limit Tes, Incremental shuttle walk test - Chronic Obstructive Pulmonary Disease, Cardiovascular Insufficiency
Not applicableTerminatedUniversity Hospital, Brest442020-02-202025-03-28
Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care
Anti-Cancer Agents - Cardiovascular Complication, Cardiovascular Insufficiency
RecruitingGroupe Hospitalier Pitie-Salpetriere50002019-03-012026-09-11
Passive Leg Raising - an Important Diagnostic Manoeuvre
Passive Leg Raising - Cardiovascular Insufficiency
Not applicableCompletedRegion MidtJylland Denmark112018-09-012021-09-24
Hydrocortisone for Term Hypotension
Hydrocortisone, Placebo - Infant, Newborn, Diseases, Cardiovascular Insufficiency
Phase 3CompletedNICHD Neonatal Research Network122014-06-192021-07-06

Narrower conditions

Cardiotoxicity (1)  ·  Chronic Disease (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Heart Diseases (1)  ·  Heart Failure (1)  ·  Hyperemia (1)  ·  Infant, Newborn, Diseases (1)  ·  Metabolic Diseases (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Vascular Diseases (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Chemically-Induced Disorders (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Disease Attributes (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Obstructive (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Radiation Injuries (1)  ·  Respiratory Tract Diseases (1)  ·  Vascular Diseases (1)  ·  Wounds and Injuries (1)

Interventions

Antineoplastic Agents (1)  ·  Hydrocortisone (1)  ·  Walk Test (1)

Sponsors

Groupe Hospitalier Pitie-Salpetriere (1)  ·  Hospices Civils de Lyon (1)  ·  NICHD Neonatal Research Network (1)  ·  Region MidtJylland Denmark (1)  ·  University Hospital, Brest (1)

Countries

France (3)  ·  Denmark (1)  ·  United States (1)

Top investigators

Abbot R Laptook, MD (1)  ·  Abhik Das, PhD (1)  ·  Barbara J Stoll, MD (1)  ·  Barbara Schmidt, MD (1)  ·  Brenda B Poindexter, MD, MS (1)  ·  Carl T D'Angio, MD (1)  ·  Edward F Bell, MD (1)  ·  Erika Fernandez, MD (1)  ·  Kathleen A Kennedy, MD, MPH (1)  ·  Krisa P Van Meurs, MD (1)  ·  Kurt Schibler, MD (1)  ·  Leif Nelin, MD (1)  ·  Michele C Walsh, MD (1)  ·  Myra Wycoff, MD (1)

Results publications

PMID 16540963, PMID 31988143

NIH funding

U10HD021364 (1), U10HD021373 (1), U10HD021385 (1), U10HD027851 (1), U10HD027853 (1), U10HD027856 (1), U10HD027880 (1), U10HD027904 (1), U10HD034216 (1), U10HD036790 (1), U10HD040461 (1), U10HD040492 (1), U10HD040689 (1), U10HD053109 (1), U10HD068244 (1)